Skip to main content
. 2021 Jun 28;13(7):978. doi: 10.3390/pharmaceutics13070978

Figure 2.

Figure 2

Representative CLS micrographs for (A) Nanovesicular carrier containing FITC, (B) a hydro-glycolic solution lacking the phospholipid containing FITC, (C) Nanovesicular carrier containing R6G and (D) a hydro-glycolic solution lacking the phospholipid containing R6G. Olympus Fluoview 300, Tokyo, Japan, Lens × 60 (Bar = 10 μm).